methylprednisolone sodium succinate - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19a"

Product details Supply Impact Dates Further Details
SOLU-MEDROL methylprednisolone (as sodium succinate) 500mg powder for injection vial with diluent vial
AUST R: 12344
Active ingredients:
methylprednisolone sodium succinate

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
01 Aug 2015

Status:
Discontinued

Patient impact:
Low

Reason:
Discontinuation

Related information:

SOLU-MEDROL methylprednisolone (as sodium succinate) 1g powder for injection vial with diluent vial
AUST R: 12340
Active ingredients:
methylprednisolone sodium succinate

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
01 Aug 2015

Status:
Discontinued

Patient impact:
Low

Reason:
Discontinuation

Related information:

SOLU-MEDROL methylprednisolone 500mg (as sodium succinate) powder for injection vial
AUST R: 50691
Active ingredients:
methylprednisolone sodium succinate

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
04 Feb 2019
to
17 Feb 2019

Status:
Anticipated

Patient impact:
Low

Reason:
Unexpected Increase in Demand